Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics.

Liu, Dan-Yang; Liu, Jia-Chen; Liang, Shuang; Meng, Xiang-He; Greenbaum, Jonathan; Xiao, Hong-Mei; Tan, Li-Jun; Deng, Hong-Wen

Liu, Dan-Yang; Liu, Jia-Chen; Liang, Shuang; Meng, Xiang-He; Greenbaum, Jonathan; Xiao, Hong-Mei; Tan, Li-Jun; Deng, Hong-Wen.

Affiliation

Liu DY; Laboratory of Molecular and Statistical Genetics, College of Life Sciences, Hunan Normal University, Changsha 410081, China.
Liu JC; Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha 410013, China.
Liang S; Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha 410013, China.
Meng XH; Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha 410013, China.
Greenbaum J; Tulane Center of Biomedical Informatics and Genomics, Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Xiao HM; Center for System Biology, Data Sciences, and Reproductive Health, School of Basic Medical Science, Central South University, Changsha 410013, China.
Tan LJ; Laboratory of Molecular and Statistical Genetics, College of Life Sciences, Hunan Normal University, Changsha 410081, China.
Deng HW; Laboratory of Molecular and Statistical Genetics, College of Life Sciences, Hunan Normal University, Changsha 410081, China.

Pharmaceutics ; 13(4)2021 Apr 14.

Article in En | MEDLINE | ID: mdl-33919660

Key words

COVID-19; SARS-CoV-2; drug repurposing; network-based pharmacology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Pharmaceutics Year: 2021 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google